Jun 17, 2020
Sirnaomics and Precision NanoSystems Have Formed a Partnership
Jun 11, 2020
Sirnaomics Announces Decision to Spin off RNAimmune to Develop Novel mRNA Therapeutics and Vaccines
Jan 24, 2020
Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV
Nov 06, 2019
Sirnaomics to Present Overview of Company's RNAi Technology Platform at Upcoming Conferences
Oct 31, 2019
Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting
Oct 09, 2019
Sirnaomics' President and CEO Patrick Lu to Give Keynote Address at RNAi China Conference
Aug 12, 2019
Global RNAi Research Report 2019: Technologies are Described, Along with Design and Methods of Manufacture of siRNA Reagents
Jun 05, 2019
RNA Therapies in Oncology Analytical Tool: 127 Companies, 274 RNA Therapy Drugs, 182 in Active Development in Cancer Across 122 Different Targets
May 16, 2019
Sirnaomics Publishes Data for Lead Candidate STP705 in Cancer Model as 2019 American Society of Clinical Oncology Annual Meeting Online Abstract
Apr 26, 2019
Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases
Apr 08, 2019
Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases
Mar 18, 2019
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
Feb 12, 2019
Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer
Jan 18, 2019
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy
Jan 09, 2019
/CORRECTION/ -- NapaJen Pharma, Inc./
Jan 09, 2019
NapaJen Pharma Closes $12.4 Million Series C Financing
Oct 25, 2018
Novel Combination Therapy Promotes Wound Healing
Oct 19, 2018
Sylentis, PharmaMar Group, Announces the End of Patient Recruitment for its HELIX Trial
Sep 25, 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Aug 16, 2018
Sirnaomics Oncology IND Receives Green Light from US FDA to Initiate Study for Treatment of Cholangiocarcinoma